HUMAN GENE TRANSFER/THERAPY PROTOCOL 
9209-030 
Deisseroth, Albert B., University of Texas MD Anderson Cancer 
Center; Use of Retroviral Markers to Evaluate the Efficacy of Purging and 
to Discriminate Between Relapse which Arises from Systemic Disease 
Remaining after Preparative Therapy Versus Relapse due to Residual 
Neoplastic Cells in Autologous Marrow Following Purging in Patients with 
Chronic Lymphocytic Leukemia (CLL). 
Date of RAC Approval: 9-14-92 
[384] 
Recombinant DNA Research, Volume 16 
